Clinical anatomy (New York, N.Y.)

Cell Death Processes and Their Possible Treatments in Parkinson's Disease: Apoptosis, Autophagy, Ferroptosis, and Necroptosis

Updated

Abstract

Parkinson's disease is associated with multiple forms of programmed cell death contributing to dopaminergic neuronal loss.

  • Distinct programmed cell death pathways—apoptosis, autophagy failure, ferroptosis, and necroptosis—are implicated in dopaminergic degeneration.
  • Post-mortem human studies reveal heterogeneous and coexisting markers of programmed cell death in neuronal subsets within the substantia nigra pars compacta.
  • Experimental models show that apoptosis is predominant in acute toxin settings, while autophagy failure, ferroptosis, and necroptosis are linked to specific genetic and environmental contexts.
  • Discrepancies between human studies and experimental models may stem from differences in timing, disease drivers, and neuronal diversity.
  • Preclinical studies suggest that targeting these death pathways could provide neuroprotection, though clinical translation remains uncertain.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free